Table 2.

Surgery and Hospital Care

Characteristics	Overall (N = 3014)	No m-SVG (N = 1969)	m-SVGs (N = 1045)	P
Emergent/emergent salvage surgery		2.9	3.1	0.802
IMA graft	92.3	93.7	89.9	<0.001
Surgery duration, median, min (25th, 75th percentiles)	231 (193, 272)	226 (190, 267)	237 (201, 280)	<0.001†
Cardiopulmonary bypass, %	78.9	74.7	86.8	<0.001
Duration of cardiopulmonary bypass, median, min (25th, 75th percentiles)	100 (79, 123)	97 (77, 121)	104 (82, 127)	<0.001
Endoscopic harvesting technique	58.4	55.7	63.5	<0.001
Postoperative duration, median (25th, 75th percentiles)
Ventilator, h	8 (5, 14)	7 (5, 13)	8 (5, 14)	0.025
Intensive care unit stay, h	26 (22, 47)	26 (22, 47)	26 (22, 48)	0.674
Hospital stay, d	6 (5, 8)	6 (5, 8)	6 (5, 8)	0.524
Worst target-artery quality				0.296
Good	43.0	42.8	43.3
Fair	35.9	35.3	37.1
Poor	21.2	21.9	19.6
Worst graft quality				0.474
Good	70.8	70.4	71.7
Fair	24.1	24.2	23.9
Poor	5.0	5.4	4.4
Medications continued at 30 d
Aspirin	90.5	91.2	89.3	0.094
Thienopyridine	21.9	22.8	20.2	0.109
ACE inhibitor	35.8	34.9	37.4	0.165
Angiotensin II receptor blocker	6.7	6.4	7.3	0.399
β-blockers	78.7	78.3	79.6	0.401
HMG-CoA reductase inhibitor	72.9	73.2	72.3	0.633

m-SVG indicates saphenous vein graft with >1 distal target; IMA, internal mammary artery; ACE, angiotensin-converting enzyme; and MHG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A.